BUL:SFAPharmaceuticals
Sopharma AD First Quarter 2025 Earnings: EPS: лв0.24 (vs лв0.23 in 1Q 2024)
Sopharma AD ( BUL:SFA ) First Quarter 2025 Results Key Financial Results Revenue: лв644.0m (up 25% from 1Q 2024). Net...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.